Glucocorticoid receptor modulator and methods of use

Details for Australian Patent Application No. 2007272504 (hide)

Owner Eli Lilly and Company

Inventors Coghlan, Michael Joseph; Carson, Matthew William

Agent Spruson & Ferguson

Pub. Number AU-B-2007272504

PCT Pub. Number WO2008/008882

Priority 60/831,166 14.07.06 US

Filing date 12 July 2007

Wipo publication date 17 January 2008

Acceptance publication date 28 June 2012

International Classifications

C07D 491/044 Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

A61K 31/4745

A61P 19/02 Drugs for skeletal disorders

Event Publications

29 January 2009 PCT application entered the National Phase

  PCT publication WO2008/008882 Priority application(s): WO2008/008882

28 June 2012 Application Accepted

  Published as AU-B-2007272504

25 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007272507-Crystalline nanostructured particles

2007272501-Nanoparticulate formulations of modafinil